Oxford Instruments (OXINF) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Right, hello and welcome to today's presentation. Delighted to see so many of you here today for my first time hosting in person, and welcome to those of us joining online. With me today is Gavin Hill, our CFO, and I'd like to take this opportunity to thank Gavin for his support in the early months, getting me up to speed and working with me to develop our updated strategy. I'm going to touch briefly on the headlines of this year's results. then talk you through our refresh strategy before handing over to Gavin to do the detail on the results. I'll come back and sum up at the end and then open things up for questions. We've delivered a robust performance in the year with revenue up 9.8% and adjusted operating profit up 3.7%, both at constant currency. Our performance has been driven by a double-digit growth in material analysis and healthcare, and a 7% increase in semiconductor revenue. Underlying book-to-bill is positive at 1.03, despite the stronger growth in H2, giving us good visibility in the year ahead. Now we've also been navigating some challenging geopolitical dynamics in relation to China. I'll provide more detail on the actions and decisions we've taken later in the strategy update. And we're continuing to invest in the business. We've completed our first quarter in our new world-class compound semiconductor facility near Bristol, which I hope many of you will be visiting next month. And we've just announced today another small acquisition, FemtoTools, adding to our imaging and analysis capabilities. Overall, a solid set of results, good growth with more to go after in the years to come. So let's move on to the future. There is no doubt that taking on the job of CEO, I was joining a great business that had been doing well. Over the last five years, the sha...